Flattening of dose curves and band-like rimming of glioblastoma cells around necrotic regions in tissue suggest that available ranges of potassium levels may need to match whatever functional complement of potassium channels is present in tumor cells. The gene discussed is KCNA3; the disease is glioblastoma.